These results, together with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the strategy of focusing on ACKR3 as a novel technique to modulate the opioid program, which could open new therapeutic avenues for opioid-related disorders. Conolidine CONOCB2™ fundamentally functions by https://louisn516hzq3.wikiannouncement.com/user